Biopharmx Corp (NYSEAMERICAN:BPMX – Get Free Report) shares were down 9.5% during trading on Monday . The company traded as low as $5.47 and last traded at $6.12. Approximately 336,508 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 2,150,348 shares. The stock had previously closed at $6.76.
Biopharmx Price Performance
About Biopharmx
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Recommended Stories
- Five stocks we like better than Biopharmx
- How Technical Indicators Can Help You Find Oversold Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.
